Search results
Tip Sheet: Funding awarded to two ovarian cancer research projects, progress towards liquid biopsies...
Newswise· 4 days agoSEATTLE — May 3, 2024 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. If you’re covering the annual meeting of ...
Keeping cancer in its place: overcoming metastasis
Nature· 5 days agoMost progress in cancer outcomes over recent decades has been driven by earlier detection and diagnosis, combined with therapies that slow the growth of...
Targeting protein interactions may boost antitumor immunity in breast cancer
Medical Xpress· 7 days agoA multi-institutional team of investigators has discovered that targeting a specific protein interaction within immunosuppressive breast cancer cells may increase antitumor ...
Lurie takes charge in studying drug that glows in presence of lung cancer cells
Crain s Chicago Business· 6 days agoCytalux, made by West Lafayette, Ind., biotech firm On Target Laboratories, is already approved for use in adults for lung, ovarian, prostate and colorectal cancers ...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
Forrest City Times-Herald· 4 days ago"The high complete response rate and durability of these responses observed in patients treated with TAR-200 underscores the potential of this treatment approach for patients...
Xyosted: Mild to serious side effects and how to manage them
Medical News Today· 5 days agoXyosted (testosterone enanthate) is a brand-name injectable drug that’s prescribed for testosterone...
New procedure allows doctors to treat liver tumors using sound waves
Scripps News via AOL· 5 days agoI was like, no, that's not the angle we're taking here." Science and Tech Study says prostate cancer...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 4 hours ago...dose escalation and targeting development of joint Amgen / IDEAYA publication strategy in 2024First-patient-in (FPI) for Phase 1 trial of IDE397 in combination with Gilead's Trodelvy® in MTAP bladder cancer targeted mid-year 2024Targeting initial Phase 2 expansion for IDE161 in HRD solid tumors...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoWe have an increased demand for Xtandi, which continues to be a backbone therapy across the prostate cancer treatment continuum. And we have continued...
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
Reuters via Yahoo Finance· 5 days agoNovartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, ...